Skandinaviska Enskilda Banken AB (publ) - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$709
-16.9%
17,526
-4.4%
0.01%
-16.7%
Q4 2022$853
-99.9%
18,338
-5.5%
0.01%
-25.0%
Q3 2022$1,006,000
+9.7%
19,4000.0%0.01%
+14.3%
Q2 2022$917,000
-33.6%
19,4000.0%0.01%
-12.5%
Q1 2022$1,381,000
+31.0%
19,400
+37.2%
0.01%
+60.0%
Q4 2021$1,054,000
+123.3%
14,141
+50.4%
0.01%
+25.0%
Q2 2020$472,000
-85.3%
9,400
-85.0%
0.00%
-76.5%
Q1 2020$3,220,000
+57.0%
62,600
+88.6%
0.02%
+6.2%
Q4 2019$2,051,000
+18.1%
33,200
+14.9%
0.02%
+6.7%
Q3 2019$1,736,000
-14.3%
28,900
+20.4%
0.02%
-11.8%
Q2 2019$2,025,000
-29.1%
24,000
-19.7%
0.02%
-34.6%
Q1 2019$2,856,000
+16.9%
29,900
-13.3%
0.03%
+18.2%
Q4 2018$2,444,000
+63.3%
34,500
-49.2%
0.02%
+29.4%
Q2 2016$1,497,000
-67.4%
67,900
-56.6%
0.02%
-67.3%
Q1 2016$4,593,000
-28.6%
156,400
-18.8%
0.05%
-37.3%
Q4 2015$6,437,000192,5000.08%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 519,035$60,156,00015.36%
Matarin Capital Management, LLC 201,703$23,377,378,0001.69%
ARMISTICE CAPITAL, LLC 124,000$14,372,0000.94%
Sapphire Star Partners LP 7,803$904,0000.93%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 98,631$11,431,0000.83%
FARALLON CAPITAL MANAGEMENT LLC 1,075,000$124,593,0000.77%
Granahan Investment Management 100,670$11,668,0000.70%
Virtus ETF Advisers LLC 6,577$762,0000.67%
AlphaMark Advisors, LLC 11,115$1,288,0000.52%
Ativo Capital Management LLC 15,029$1,742,0000.48%
View complete list of ENANTA PHARMACEUTICALS INC shareholders